Poseida Therapeutics, Inc. Loss on Contract Termination
Poseida Therapeutics, Inc. reported Loss on Contract Termination of $5.69 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Notes
us-gaap:LossOnContractTermination · last filed 2023-08-08
- Poseida Therapeutics, Inc. loss on contract termination for the quarter ending 2022-03-31 was $8.07M.
| Period end | Loss on Contract Termination 3 month | Loss on Contract Termination 6 month |
|---|---|---|
| 2022-06-30 | $5.69M 10-Q · filed 2023-08-08 | |
| 2022-03-31 | $8.07M 10-Q · filed 2023-05-09 |